⌘K

Home/Filings/4/0001516551-25-000018

4//SEC Filing

ARSENAULT KAITLYN 4

Accession 0001516551-25-000018

CIK 0001516551other

View on SEC.gov Company Profile

Filed

Feb 25, 7:00 PM ET

Accepted

Feb 26, 5:53 PM ET

Size

5.7 KB

Accession

0001516551-25-000018

Insider Transaction Report

Form 4

Period: 2025-02-24

Skye Bioscience, Inc.SKYE

ARSENAULT KAITLYN

Chief Financial Officer

Transactions

Award
Stock Option (Right to Buy)
2025-02-24+150,000→ 150,000 total
Exercise: $2.89Exp: 2035-02-25→ Common Stock (150,000 underlying)

Footnotes (1)

[F1]The stock option vests in equal monthly installments over the four year period beginning February 21, 2025.

Documents

1 file

4
wk-form4_1740610387.xmlPrimary
FORM 4

Issuer

Skye Bioscience, Inc.

CIK 0001516551

Entity typeother

Related Parties

1

filerCIK 0001877242

Filing Metadata

Form type: 4
Filed: Feb 25, 7:00 PM ET
Accepted: Feb 26, 5:53 PM ET
Size: 5.7 KB

View on SEC.gov